DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,122 filers reported holding DANAHER CORPORATION in Q2 2024. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $283,582 | -12.0% | 1,135 | -12.0% | 0.15% | -18.3% |
| Q1 2024 | $322,139 | +3.5% | 1,290 | -4.1% | 0.18% | -1.6% |
| Q4 2023 | $311,156 | -31.5% | 1,345 | -26.5% | 0.18% | -38.2% |
| Q3 2023 | $454,029 | +2.1% | 1,830 | -1.2% | 0.30% | +8.8% |
| Q2 2023 | $444,720 | -7.6% | 1,853 | -2.9% | 0.27% | -11.4% |
| Q1 2023 | $481,146 | -11.1% | 1,909 | -6.4% | 0.31% | -12.0% |
| Q4 2022 | $541,459 | -5.0% | 2,040 | -7.6% | 0.35% | -8.6% |
| Q3 2022 | $570,000 | -5.9% | 2,208 | -7.6% | 0.38% | +1.9% |
| Q2 2022 | $606,000 | -15.6% | 2,390 | -2.4% | 0.38% | +4.2% |
| Q1 2022 | $718,000 | -18.0% | 2,448 | -8.0% | 0.36% | -16.7% |
| Q4 2021 | $876,000 | +3.9% | 2,661 | -3.8% | 0.43% | -3.8% |
| Q3 2021 | $843,000 | +13.6% | 2,766 | +0.1% | 0.45% | +15.1% |
| Q2 2021 | $742,000 | +17.0% | 2,764 | -1.9% | 0.39% | +13.4% |
| Q1 2021 | $634,000 | +6.4% | 2,817 | +4.9% | 0.34% | -2.0% |
| Q4 2020 | $596,000 | +9.0% | 2,686 | +5.7% | 0.35% | -5.6% |
| Q3 2020 | $547,000 | +35.4% | 2,541 | +11.3% | 0.37% | +30.5% |
| Q2 2020 | $404,000 | +38.8% | 2,283 | +8.4% | 0.28% | +18.8% |
| Q1 2020 | $291,000 | +1.4% | 2,106 | +12.6% | 0.24% | +36.4% |
| Q4 2019 | $287,000 | +1.8% | 1,870 | -4.1% | 0.18% | -2.8% |
| Q3 2019 | $282,000 | -10.2% | 1,950 | -11.4% | 0.18% | -8.6% |
| Q2 2019 | $314,000 | 0.0% | 2,200 | -7.6% | 0.20% | 0.0% |
| Q1 2019 | $314,000 | +27.6% | 2,380 | -0.4% | 0.20% | +20.0% |
| Q4 2018 | $246,000 | -7.2% | 2,390 | -2.0% | 0.16% | +7.8% |
| Q3 2018 | $265,000 | +7.7% | 2,440 | -2.0% | 0.15% | +7.0% |
| Q2 2018 | $246,000 | 0.0% | 2,490 | -1.0% | 0.14% | -1.4% |
| Q1 2018 | $246,000 | -7.9% | 2,515 | -12.5% | 0.14% | -5.2% |
| Q4 2017 | $267,000 | +8.1% | 2,875 | 0.0% | 0.15% | +13.3% |
| Q3 2017 | $247,000 | +0.8% | 2,875 | -0.9% | 0.14% | -1.5% |
| Q2 2017 | $245,000 | -1.2% | 2,900 | 0.0% | 0.14% | -2.1% |
| Q1 2017 | $248,000 | +9.7% | 2,900 | 0.0% | 0.14% | +6.9% |
| Q4 2016 | $226,000 | -3.8% | 2,900 | -3.3% | 0.13% | -9.7% |
| Q3 2016 | $235,000 | -23.2% | 3,000 | -0.8% | 0.14% | -24.5% |
| Q2 2016 | $306,000 | -10.8% | 3,025 | -16.3% | 0.19% | -12.3% |
| Q1 2016 | $343,000 | -5.8% | 3,615 | -7.7% | 0.22% | +1.4% |
| Q4 2015 | $364,000 | – | 3,915 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |